Good Oncologist: Doctoring Lessons From the Art of Oncology
E
Emily Zaltz
(Department of Oncology, St Jude Children's Research Hospital, Memphis, TN)
C
Calliope Reeves
(Department of Oncology, St Jude Children's Research Hospital, Memphis, TN)
H
Harmony Farner
(Department of Oncology, St Jude Children's Research Hospital, Memphis, TN)
E
Erin Batchelor
(Department of Oncology, St Jude Children's Research Hospital, Memphis, TN)
M
Meaghann S. Weaver
(Department of Oncology, St Jude Children's Research Hospital, Memphis, TN)
E
Erica C. Kaye
(Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN)
Abstract
Qualitative analysis of narrative essays authored by cancer care professionals offer insights into what it means to be a “good oncologist.”
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 12
Published
April 20, 2026
Pages
1166-1173
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (6)
E
Emily Zaltz
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
C
Calliope Reeves
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
H
Harmony Farner
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
E
Erin Batchelor
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
M
Meaghann S. Weaver
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
E
Erica C. Kaye
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001